Foster Group
AZN icon

Foster Group’s AstraZeneca AZN Stock Holding History

Foster Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$306K Sell
1,894
-159
-8% -$26.5K 0.01% 243
2026
Q2 		$389K Buy
+2,053
New +$386K 0.01% 208
2026
Q1 		– Sell
-1,536
Closed -$282K – 289
2025
Q4 		$282K Buy
1,536
+209
+16% +$36.7K 0.01% 224
2025
Q3 		$204K Buy
+1,327
New +$201K 0.01% 260

Other funds holding AZN

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Border to Coast Pensions Partnership
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
ASR Vermogensbeheer
ASR Vermogensbeheer Utrecht, Netherlands $10.1B AUM 30.4% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
ZWJ Investment Counsel
ZWJ Investment Counsel Atlanta, Georgia $3.24B AUM 31.6% 1-Year Est. Return
Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Oslo Pensjonsforsikring
Oslo Pensjonsforsikring Oslo $863M AUM 18.29% 1-Year Est. Return
Professional Advisory Services
Professional Advisory Services Vero Beach, Florida $837M AUM 20.44% 1-Year Est. Return

Foster Group's AZN Position: Q3 2026 in Review

Foster Group reduced its AstraZeneca (AZN) stake by 7.7% in Q3 2026, selling an estimated $26.5K and leaving 1,894 shares worth $306K. The position accounts for 0.01% of the portfolio, ranked #243.

Foster Group first reported a position in AZN in Q3 2025 and has held it in 4 quarters since. The position peaked at $389K in Q2 2026. 218 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Foster Group held 1,894 shares of AstraZeneca worth $306K as of Q3 2026.
  • Foster Group sold 159 AstraZeneca shares in Q3 2026, an estimated $26.5K.
  • AstraZeneca made up 0.01% of Foster Group's portfolio in Q3 2026, its #243 holding.
  • Foster Group first reported a position in AstraZeneca in Q3 2025 and has held it in 4 quarters since.
  • Foster Group's AstraZeneca position peaked at $389K in Q2 2026.
  • 218 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Foster Group's 13F filing for Q3 2026, filed 13 Oct 2026.